ITeos Therapeutics Q2 EPS $(0.75) Misses $(0.41) Estimate
ITeos Therapeutics (NASDAQ:ITOS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.41) by 82.93 percent. This is a 97.46 percent increase over losses of $(29.49) per share